|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
CVS » Topics » The merger may not be accretive and may cause dilution to our earnings per share, which may harm the market price of our common stock.This excerpt taken from the CVS 10-K filed Feb 27, 2007. The merger may not be accretive and may cause dilution to our earnings per share, which may harm the market price of our common stock. We currently anticipate that the merger will be accretive to earnings per share during the first full calendar year after the merger. However, due to legal restrictions, we have been limited in our ability to complete and finalize an integration plan relating to the merger of the two companies. Accordingly, this expectation is based on preliminary estimates which may materially change after the completion of the merger. We could also encounter additional transaction and integration-related costs or other factors such as the failure to realize all of the benefits anticipated in the merger. All of these factors could cause dilution to our earnings per share or decrease or delay the expected accretive effect of the merger and cause a decrease in the price of our common stock. |
| |||||||